NCT00874484已完成2 期
Enoxaparin as Treatment for Vulvar Vestibulitis Syndrome - Vulvodynia
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- vestibular pain
研究概览
简要总结
The investigators hypothesize that injections of Low molecular weight heparin (LMWH) [enoxaparin] will reduce pain in women with vulvodynia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 19 Years 至 50 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •women with vulvodynia
排除标准
- •women without vulvodynia
研究组 & 干预措施
1
Experimental
干预措施: Clexane (enoxaparin) (Drug)
2
Placebo Comparator
干预措施: Clexane (enoxaparin) (Drug)
结局指标
主要结局
vestibular pain
时间窗: one year
次要结局
未报告次要终点
研究者
Prof. Jacob Bornstein
Chair, Dpt Obstetrics & Gynecology
Western Galilee Hospital-Nahariya
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)Atrial FibrillationNCT00289042The Cleveland Clinic200
Unknown
4 期
Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.Hemodialysis PatientsNCT01970280Dr. Sidney Ben Chetrit26
Unknown
3 期
Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH DoseVenous ThromboembolismNCT02486666Hamilton Health Sciences Corporation20
已完成
2 期
Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.Venous ThrombosisNCT00878826Stanford University11
终止
不适用
Enoxaparin and/or Minocycline in Acute StrokeAcute Ischemic StrokeNCT00836355NYU Langone Health6
